Screening for proteinuria and chronic kidney disease risk factors in Kinshasa: A world kidney day 2007 study

Nephron - Clinical Practice

Volumn 110, Issue 4, 2008, Pages

  Sumaili, Ernest K ^a,b   Nseka, Nazaire M ^a   Lepira, François B ^a   Krzesinski, Jean Marie ^b   Makulo, Jean Robert R ^a   Bukabau, Justine B ^a   Nkoy, Josée B ^a   Mokoli, Vieux M ^a   Longokolo, Murielle M ^a   Owandjalola, Julie A ^a   Kayembe, Patrick K ^a  

^a UNIVERSITY OF KINSHASA   (Congo)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Chronic kidney disease; Developing countries; Diabetes mellitus; Early detection

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHILD; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INTERVIEW; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RISK FACTOR; SCHOOL CHILD; SCREENING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COMORBIDITY; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MASS SCREENING; MIDDLE AGED; PROTEINURIA; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 54949142175     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167869     Document Type: Article

References (43)

1. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H: The burden of kidney disease: improving global outcomes. Kidney Int 2004;66:1310-1314.
2. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: approaches and initiatives. A position statement from Kidney Disease Improving Global Outcomes (KDIGO). Kidney Int 2007;72:247-259.
3. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12.
4. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study Group: urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in general population. Circulation 2002;106:1777-1782.
5. Plata R, Silva C, Yahuita J, Perez L, Schieppati A, Remuzzi G: The first clinical and epidemiological programme on renal disease in Bolivia: a model for prevention and early diagnosis of renal diseases in the developing countries. Nephrol Dial Transplant 1998;13:3034-3036.
6. Krzesinski JM, Sumaili EK, Cohen EP: How to tackle the avalanche of chronic kidney disease in sub-Saharan Africa: the situation in the Democratic Republic of Congo as an example. Nephrol Dial Transplant 2007;22:332-335.
7. Barsoum RS: Epidemiology of end stage renal disease (ESRD): a worldwide perspective; in El Nahas M (ed): Kidney Diseases in the Developing World and Ethnic Minorities. New York, Taylor and Francis, 2005, pp 1-13.
8. Ifudu O, Friedman EA: Management chronic renal insufficiency: intertwined roles of non-nephrologist and nephrologist. J Natl Med Assoc 2003;95:43-54.
9. Iseki K, Ikemiya V, Fukiyama K: Risk factors of end stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 1997;51:850-854.
10. Pinto-Sietsma SJ, Jannsen WMT, Hillege HL, Navis G, de Zeeuw D, de Jong PE: Urinary albumin excretion is associated with renal functional abnormalities in non-diabetic population. J Am Soc Nephrol 2000;11:1882-1888.
11. Hillege HL, Janssen WM, Bak AA, Diercks GK, Grobbee DE, Crijns HJ: Microalbuminuria is common also in a nondiabetic nonhypertensive population and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001;249:519-526.
12. Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT: Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol 2006;17:331-335.
13. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PWF, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844-850.
14. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guidelines population screening: results from the NHANES III. Kidney Int 2002;61:2165-2175.
15. Ramirez SPB, McClellan W, Port FK, Hsu SI: Risk factors for proteinuria in a large, multiracial, Southeast Asian population. J Am Soc Nephrol 2002;13:1907-1917.
16. Arogundade FA, Barsoum RS: CKD prevention in sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis 2008;51:515-523.
17. Couser WG, Shah S, Kopple J, Beerkens P, Wilson A, Feehally J, Reiser T, Riella M: A call to action on World Kidney Day, 8 March 2007. Kidney Int 2007;71:369-370.
18. Sumaili EK, Krzesinski JM, Zinga CV, Cohen EP, Delanaye P, Munyanga SM, Nseka NM: Prevalence of chronic kidney disease in Kinshasa, the Democratic Republic of Congo. Abstract presented to the ERA-EDTA XLV Congress in Sweden, May 10-13, 2008;Stockholm. http://www.postersessiononline.eu/aula_vis.asp (accessed July 14, 2008).
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
20. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
22. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26(suppl 1):S5-S20.
23. McDonald SP, Maguire GP, Hoy WE: Renal function and cardiovascular risk markers in a remote Australian Aboriginal community. Nephrol Dial Transplant 2003;18:1555-1561.
24. Katz IJ, Hoy WE, Kondalsamy-Chennakesavan S, Gerntholtz T, Scheppingen J, Sharma S, Butler O, Shezi E, Mdleleni G, Mthombeni D: Chronic kidney disease management: what can we learn from South African and Australian Efforts? Blood Purif 2006;24:115-122.
25. Brown WW, Peters RM, Ohmit SE, Keane WF, Keane WF, Collins A, Chen SC, King K, Klag MJ, Molony DA, Flack JM: Early detection of kidney disease in community settings. The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2003;42:22-35.
26. Davidson MB, Smiley JF: Relationship between dipstick positive proteinuria and albumin: creatinine ratios. J Diabetes Complications 1999;13:52-55.
27. Yamagata K, Iseki K, Nitta K, Imai H, Lino Y, Matsuo S, Makino H, Hishida A: Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clinic Exp Nephrol 2008;12:1-8.
28. Iseki K, Ikemiya Y, Iseki C, Takishita S: Proteinuria and the risk of developing end stage renal disease. Kidney Int 2003;63:1468-1474.
29. Sam R, Shaykh MS, Pegoraro AA, Khalil V, Hristea I, Singh AK, Arruda JAL, Dunea G: The significance of trace proteinuria. Am J Nephrol 2003;23:438-441.
30. Konta T, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T, Ikeda A, Ichikawa K, Kato T, Kawata S, Kubota I: Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol 2007;11:51-55.
31. Neugarten J, Gallo G, Silbiger S, Kasiske B: Glomerulosclerosis in aging humans is not influenced by gender. Am J Kidney Dis 1999;34:884-888.
32. Mulder WJ, Hillen HF: Renal function and renal disease in the elderly. Part II. Eur J Intern Med 2001;12:327-333.
33. United States Renal Data System: Incidence and prevalence of ESRD; in USRDS 1999 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999, pp 25-38.
34. Grimm RH, Svendsen KH, Kasiske B, Keane WF, Wahi MM, MRFIT Research Group: Proteinuria is a risk factor for mortality over 10 years follow-up. Multiple Risk Factor Intervention Trial. Kidney Int 1997;52(suppl 63):S10-S14.
35. Bianchi S, Bigazzi R, Campese VM: Microalbuminuria in essential hypertension: significance, pathophysiology and therapeutic implications. Am J Kidney Dis 1999;34:973-995.
36. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004;140:167-174.
37. Stehouwer CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM: Microalbuminuria is associated with impaired brachial artery flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction. The Hoorn Study. Kidney Int Suppl 2004;92:S42-S44.
38. de Jong PE, Brenner BM: From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int 2004;66:2109-2118.
39. Cho BS, Kim SD: School urinalysis screening in Korea. Nephrology 2007;12:S3-S7.
40. El Nahas AM: Global challenge of chronic kidney disease. Kidney Int 2005;68:2918-2929.
41. Pakasa NM, Sumaili EK: The nephrotic syndrome in the Democratic Republic of Congo. N Engl J Med 2006;354:1085-1086.
42. K/DOQI: Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002;39(2 suppl):S21-S266.
43. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR: Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA 2003;290:3101-3114.